News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
276,713 Results
Type
Article (14433)
Company Profile (111)
Press Release (262169)
Section
Business (91899)
Career Advice (468)
Deals (16415)
Drug Delivery (64)
Drug Development (38160)
Employer Resources (50)
FDA (6676)
Job Trends (6535)
News (157411)
Policy (14700)
Tag
Academia (449)
Alliances (24094)
Alzheimer's disease (365)
Approvals (6676)
Artificial intelligence (62)
Bankruptcy (144)
Best Places to Work (4540)
Biotechnology (45)
Breast cancer (43)
Cancer (335)
Career advice (410)
Cell therapy (53)
Clinical research (31789)
Collaboration (165)
Compensation (65)
COVID-19 (763)
C-suite (53)
Data (374)
Diabetes (57)
Diagnostics (1345)
Drug pricing (57)
Earnings (33349)
Employer resources (44)
Events (38601)
Executive appointments (178)
FDA (6868)
Funding (112)
Gene therapy (59)
GLP-1 (295)
Government (1297)
Healthcare (3773)
Infectious disease (784)
Inflammatory bowel disease (46)
Interviews (58)
IPO (6212)
Job creations (2191)
Job search strategy (377)
Layoffs (169)
Legal (3650)
Lung cancer (49)
Manufacturing (99)
Medical device (1609)
Medtech (1611)
Mergers & acquisitions (10247)
Metabolic disorders (174)
Neuroscience (467)
NextGen Class of 2024 (1616)
Non-profit (603)
Northern California (447)
Obesity (103)
Opinion (110)
Patents (53)
People (29512)
Pharmaceutical (64)
Phase I (8290)
Phase II (13382)
Phase III (12051)
Pipeline (191)
Policy (45)
Postmarket research (1534)
Preclinical (3277)
Radiopharmaceuticals (121)
Rare diseases (90)
Real estate (2714)
Regulatory (10268)
Research institute (582)
Resumes & cover letters (55)
Southern California (444)
Startups (1678)
United States (4424)
Vaccines (117)
Weight loss (78)
Date
Today (52)
Last 7 days (277)
Last 30 days (1342)
Last 365 days (13310)
2024 (12178)
2023 (14956)
2022 (21160)
2021 (21803)
2020 (20484)
2019 (15671)
2018 (12180)
2017 (14750)
2016 (13857)
2015 (16490)
2014 (13166)
2013 (11158)
2012 (12014)
2011 (12449)
2010 (11409)
Location
Africa (321)
Arizona (43)
Asia (20097)
Australia (2613)
California (1032)
Canada (608)
China (112)
Colorado (44)
Connecticut (42)
Europe (47603)
Florida (154)
Illinois (114)
Indiana (87)
Japan (44)
Kansas (52)
Maryland (164)
Massachusetts (927)
Minnesota (58)
New Jersey (426)
New York (286)
North Carolina (298)
Northern California (447)
Pennsylvania (307)
South America (516)
Southern California (444)
Texas (138)
Virginia (41)
Washington State (76)
276,713 Results for "powderject pharmaceuticals plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
November 11, 2024
·
3 min read
Hemogenyx Pharmaceuticals PLC Announces Operations Update - June 17, 2024
Hemogenyx Pharmaceuticals plc, the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its ongoing activities and progress.
June 17, 2024
·
4 min read
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting - June 27, 2024
Hemogenyx Pharmaceuticals plc is pleased to announce that, at the Annual General Meeting held earlier , all resolutions were duly passed on a show of hands.
June 27, 2024
·
2 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Schedule for Phase I Clinical Trial Opening
October 30, 2024
·
4 min read
Press Releases
Angle PLC Announces Agreement with Recursion Pharmaceuticals
September 19, 2024
·
2 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
September 27, 2024
·
9 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC
October 2, 2024
·
6 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces CDX Development Update
September 2, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Presentation at CBD S&T Conference
August 28, 2024
·
2 min read
Hemogenyx Pharmaceuticals PLC Announces CBR Intranasal Delivery
Hemogenyx Pharmaceuticals plc announces that it has demonstrated in vivo that its proprietary Chimeric Bait Receptor can be delivered intranasally in the form of messenger RNA for the potential treatment of airborne viral infections.
February 14, 2024
·
3 min read
1 of 27,672
Next
